HEPATITIS-C IN THE HEALTH-CARE SETTING .2. SEROPREVALENCE AMONG HEMODIALYSIS STAFF AND PATIENTS IN SUBURBAN NEW-YORK-CITY

被引:18
作者
FORSETER, G
WORMSER, GP
ADLER, S
LEBOVICS, E
CALMANN, M
OBRIEN, TA
机构
[1] Divisions of Infectious Diseases, Nephrology, Gastroenterology, Valhalla, NY
[2] Department of Medicine, New York Medical College, Valhalla, NY
[3] Ortho Diagnostic Systems, Inc., Raritan, NJ
关键词
D O I
10.1016/0196-6553(93)90200-N
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Hepatitis C virus (HCV) is a newly identified blood-borne virus that may pose an occupational hazard for health care workers. Hemodialysis nurses could be anticipated to be at high risk for HCV infection because this group of health care workers frequently comes into contact with blood of a patient population with a seroprevalence rate of at least 10%. Methods: To assess the risk of HCV infection for hemodialysis nurses, serum samples from all of the nurses (22/22, 100%) and patients (125/125, 100%) in one hemodialysis unit (unit A) and 85% (29/34) of nurses from a second unit (unit B), both units in suburban New York City, were tested for HCV antibodies. Samples with positive results of enzyme-linked immunosorbent assay underwent supplemental testing by a first-generation recombinant immunoblot assay. Results: Twenty-four (19%) of the hemodialysis patients in unit A were HCV seropositive. Despite an average of 4.7 years spent working in hemodialysis unit A, none of the nurses tested seropositive for HCV antibody. In unit B, despite an average of 6.4 years working in the unit studied, only one nurse tested seropositive for HCV antibody. This nurse reported a long history of elevated liver function values and a negative HBV core antibody status that predated her hemodialysis nursing career. Conclusions: In contrast to the experience with hepatitis B virus infection, hemodialysis nurses appear to be at low risk for occupationally acquired HCV infection.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 29 条
[21]  
Seef, Hepatitis C from a needlestick [Letter], Annals of Internal Medicine, 115, (1991)
[22]  
Schlipkoter, Roggendorf, Cholmakow, Weise, Dienhardt, Transmission of hepatitis C virus from a hemodialysis patient to a medical staff member, Scandinavian Journal of Infectious Diseases, 22, pp. 757-758, (1990)
[23]  
Patti, Sand, Pompa, Et al., HCV and occupational hazard, Third International Symposium on HCV, (1991)
[24]  
Farci, London, Wong, Et al., The natural history with hepatitis C virus in chimpanzees: comparison of serologic responses measured with first and second gen eration assays and relationship to HCV viremia, J Infect Dis, 165, pp. 1006-1011, (1992)
[25]  
Alter, Hadler, Judson, Et al., Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection, JAMA, 264, pp. 2231-2235, (1990)
[26]  
Wormser, Forseter, Joline, Tupper, O'Brien, Hepatitis C infection in the health care setting 1 Low risk from parenteral exposure to blood of HIV-infected patients, American Journal of Infection Control, 5, pp. 237-242, (1991)
[27]  
Wormser, Forseter, Bittker, Et al., Hepatitis C virus infection in medical students prospectively followed over 4 years, Third International Symposium on HCV, (1991)
[28]  
Yoshizawa, Itoh, Iwakiri, Et al., Non-A, Non-B [type 1] hepatitis agents capable of inducing tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat, Gastroenterology, 82, pp. 502-506, (1982)
[29]  
Shikata, Karasawa, Abe, Et al., Hepatitis B e antigen and infectivity of hepatitis B virus, J Infect Dis, 136, pp. 571-576, (1977)